Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin. 2022

Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
Department of Virology, Paul-Ehrlich-Institut, Langen, Germany.

Zika virus (ZIKV) is a flavivirus that is mainly transmitted by Aedes mosquitos and normally causes mild symptoms. During the outbreak in the Americas in 2015, it was associated with more severe implications, like microcephaly in newborns and the Guillain-Barré syndrome. The lack of specific vaccines and cures strengthens the need for a deeper understanding of the virus life cycle and virus-host interactions. The restriction factor tetherin (THN) is an interferon-inducible cellular protein with broad antiviral properties. It is known to inhibit the release of various enveloped viruses by tethering them to each other and the cell membrane, thereby preventing their further spread. On the other hand, different viruses have developed various escape strategies against THN. Analysis of the cross-talk between ZIKV and THN revealed that, despite a strong induction of THN mRNA expression in ZIKV-infected cells, this is not reflected by an elevated protein level of THN. Contrariwise, the THN protein level is decreased due to a reduced half-life. The increased degradation of THN in ZIKV infected cells involves the endo-lysosomal system but does not depend on the early steps of autophagy. Enrichment of THN by depletion of the ESCRT-0 protein HRS diminishes ZIKV release and spread, which points out the capacity of THN to restrict ZIKV and explains the enhanced THN degradation in infected cells as an effective viral escape strategy. IMPORTANCE Although tetherin expression is strongly induced by ZIKV infection there is a reduction in the amount of tetherin protein. This is due to enhanced lysosomal degradation. However, if the tetherin level is rescued then the release of ZIKV is impaired. This shows that tetherin is a restriction factor for ZIKV, and the induction of an efficient degradation represents a viral escape strategy. To our knowledge, this is the first study that describes and characterizes tetherin as a restriction factor for the ZIKV life cycle.

UI MeSH Term Description Entries
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D010750 Phosphoproteins Phosphoprotein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071244 Zika Virus An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas. Virus, Zika,ZikV
D000090103 Antiviral Restriction Factors A broad category of endogenous host cellular factors upregulated in response to pathogens (i.e., INTERFERON-stimulated genes) and recruited to interfere with VIRAL REPLICATION and/or trigger host antiviral CELLULAR IMMUNE RESPONSE. Antiviral Effectors,Cellular Restriction Factors,Host Cell Restriction Factors,Restriction Factors, Antiviral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
April 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
January 2003, Insight (American Society of Ophthalmic Registered Nurses),
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
July 2018, South Dakota medicine : the journal of the South Dakota State Medical Association,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
November 2012, European heart journal,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
April 2014, European heart journal,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
February 2016, eLife,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
February 2012, International journal of cardiology,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
June 2017, Heart rhythm,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
May 2004, Nature structural & molecular biology,
Marie-Luise Herrlein, and Paul Schmanke, and Fabian Elgner, and Catarina Sabino, and Sami Akhras, and Daniela Bender, and Mirco Glitscher, and Denna Tabari, and Catharina Scholl, and Julia Stingl, and Eberhard Hildt
December 2009, Nature chemistry,
Copied contents to your clipboard!